|Articles|March 3, 2011

Oracle Introduces Oracle(r) Health Sciences Central Coding 3.0

Oracle today announced the availability of Oracle® Health Sciences Central Coding Release 3.0.  The third generation of the Web-based clinical trial data coding and dictionary management application includes expanded query management and automated workflows that help clinical trial sponsors and contract research organizations (CROs) improve the efficiency and consistency of the coding process.

Oracle Health Sciences Central Coding Release 3.0 features enhanced integration with Oracle Health Sciences InForm Global Trial Management Global Trial Management system, which promotes greater productivity via improved query management and workflow. This release enables users to create and manage Oracle Health Sciences InForm Global Trial Management queries directly in Oracle Health Sciences Central Coding Release 3.0, streamlining the coding process with one point of entry to apply and manage coding updates to all Oracle Health Sciences InForm Global Trial Management-managed trials in process.

It features:

  • A flexible, multilingual application that automates coding and minimizes the manual effort required to code verbatim terms, Oracle Health Sciences Central Coding Release 3.0 is the first coding solution to be certified by the Uppsala Monitoring Center, the World Health Organization collaborative center for international drug monitoring.

  • A new user interface and simplified status information. Customizable flags and status options enable users to tailor and optimize their workflow.

  • Auto-query, propagate, and auto-close tools enhance productivity by reducing the manual effort required to raise and resolve queries.




     

Related to this article

© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.